Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02468895Active Not Recruiting

MYOPROSP - a Prospective Cohort Study in Myositis

Role: collaborator

NCT03065660Phase 3Completed

Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage

Role: collaborator

NCT04326855Not ApplicableUnknown

Validation of an Intermittent Shuttle Walking Protocol in Patients With COPD

Role: collaborator

NCT01738711Not ApplicableUnknown

Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients

Role: lead

NCT01569906Completed

Narrowband UVB for Children With Moderate to Severe Atopic Eczema

Role: lead

All 5 trials loaded